1. Home
  2. MIST vs FORA Comparison

MIST vs FORA Comparison

Compare MIST & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • FORA
  • Stock Information
  • Founded
  • MIST 2003
  • FORA 2014
  • Country
  • MIST Canada
  • FORA United States
  • Employees
  • MIST N/A
  • FORA N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • FORA Computer Software: Prepackaged Software
  • Sector
  • MIST Health Care
  • FORA Technology
  • Exchange
  • MIST Nasdaq
  • FORA Nasdaq
  • Market Cap
  • MIST 81.5M
  • FORA 63.8M
  • IPO Year
  • MIST N/A
  • FORA N/A
  • Fundamental
  • Price
  • MIST $1.43
  • FORA $2.10
  • Analyst Decision
  • MIST Strong Buy
  • FORA Strong Buy
  • Analyst Count
  • MIST 3
  • FORA 1
  • Target Price
  • MIST $13.00
  • FORA $5.00
  • AVG Volume (30 Days)
  • MIST 177.8K
  • FORA 14.2K
  • Earning Date
  • MIST 11-11-2024
  • FORA 11-07-2024
  • Dividend Yield
  • MIST N/A
  • FORA N/A
  • EPS Growth
  • MIST N/A
  • FORA N/A
  • EPS
  • MIST N/A
  • FORA 0.06
  • Revenue
  • MIST N/A
  • FORA $20,371,880.00
  • Revenue This Year
  • MIST N/A
  • FORA N/A
  • Revenue Next Year
  • MIST N/A
  • FORA $10.64
  • P/E Ratio
  • MIST N/A
  • FORA $36.34
  • Revenue Growth
  • MIST N/A
  • FORA 6.97
  • 52 Week Low
  • MIST $1.12
  • FORA $2.00
  • 52 Week High
  • MIST $3.52
  • FORA $4.15
  • Technical
  • Relative Strength Index (RSI)
  • MIST 42.50
  • FORA 38.13
  • Support Level
  • MIST $1.41
  • FORA $2.05
  • Resistance Level
  • MIST $1.53
  • FORA $2.16
  • Average True Range (ATR)
  • MIST 0.07
  • FORA 0.05
  • MACD
  • MIST -0.01
  • FORA 0.00
  • Stochastic Oscillator
  • MIST 26.96
  • FORA 31.77

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About FORA Forian Inc.

Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.

Share on Social Networks: